Original article / research
Evaluation of Efficacy and Safety of Epalrestat (150 mg) Compared to Epalrestat (50 mg) in Patients Suffering from Diabetic Peripheral Neuropathy
Published: April 1, 2018 | DOI: https://doi.org/10.7860/JCDR/2018/32716.11444
Sachin Devendrarao Shende, Mirza Shiraz Baig, Sudhakar Madhukar Doifode
|